“Effect of DOPA decarboxylase inhibitor supplements on the incidence of urinary tract infections in Parkinson’s disease patients: A systematic review and meta-analysis of randomized controlled trials”, Arch Ital Urol Androl, vol. 96, no. 4, Oct. 2024, doi: 10.4081/aiua.2024.12833.